ESS vs TRDA · P/E 31, rev $1.89B vs P/E 12, rev $210.8M
Essex Property Trust Inc (ESS) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the ESS and TRDA stock pages for the full models.
Not investment advice.